Life Sciences, Medical Devices, & Healthcare Investor Mandate Interview

TL;DR

Yaniv discusses angel investing in life sciences, emphasizing the importance of FDA approval and the need for diverse expertise within angel investor groups.

Transcript

Lois's Richard C Wilson and welcome to this investor mandate interview we have with this yaniv today who's going to be talking about angel investing and also he comes from the Northeast area in the United States has been at a few of our events before so welcome Univ thank you thanks for hundred great so um how would you describe your self as an inv... Read More

Key Insights

• 😇 Mid-Atlantic is a life science angel investor group focused on therapeutics, devices, and diagnostics globally.
• 😨 FDA approval is a critical requirement for their investments, and they actively seek products that can change the standard of care.
• 😇 Diverse expertise within an angel investor group helps evaluate complex investments in the life science sector.
• 🤩 Strong management, transformative products, and large, growing markets are key criteria for investment opportunities.
• 🤗 Leveraging the wisdom of the crowd and engaging in open conversations can lead to better investment decisions.
• 👥 Investing as part of a group mitigates individual knowledge gaps and enhances investment outcomes.
• 🔬 A background in both science and business is necessary for angel investors in the life sciences sector.
• 😇 The majority of angel investor group members have medical or pharmaceutical backgrounds, while others bring diverse expertise to the table.

Questions & Answers

Q: How do you mitigate the fear of FDA approval among potential investors?

Yaniv suggests investing as part of a group to benefit from collective knowledge and expertise. The group's wisdom helps make more informed investment decisions, especially in a complex area like life sciences.

Q: What type of individuals are part of your angel investor group?

The majority of the group consists of doctors, dentists, and individuals working in pharma and device companies. However, there are also members from diverse backgrounds such as finance and HR, providing a well-rounded perspective.

Q: What are the main criteria your firm looks for in potential investments?

Strong management is a top priority. The firm also seeks products that can substantially change the standard of care and target large, growing markets for a successful exit via M&A.

Q: What advice would you give to investors to avoid pitfalls in their investment journey?

Yaniv emphasizes the wisdom of the crowd, advising investors to never invest alone. Recruiting knowledgeable individuals and engaging in open conversations about potential investments can help avoid bad deals and gain better access to investment opportunities.

Summary & Key Takeaways

• Yaniv is a part of the Mid-Atlantic life science angel investor group, which exclusively invests in therapeutics, devices, and diagnostic companies globally.

• FDA approval is a crucial requirement for their investments. Yaniv recommends investing as part of a group to leverage collective wisdom and diverse knowledge.

• Expertise in both science and business, along with an understanding of who will pay for the product, is essential for successful investments in the life sciences sector.